@pagingdrfran's birth control for perimenopause advice checked

What did @pagingdrfran actually say?

The claim here is straightforward: combined hormonal birth control pills can function as a "three-in-one" hormone replacement during perimenopause, delivering estrogen for symptom control, progestin for uterine protection, and contraception against pregnancy. She also argued that women under 50 whose symptoms aren't controlled by the pill should transition to traditional HRT, and that a Mirena IUD can serve as the progestin component when adding an estrogen patch or pill. The age-50 mark, she said, is a common inflection point for switching.

This is a clinically grounded take. She's not selling anything exotic, and she's not overstating the evidence. The framing is pragmatic and reflects how a lot of ob-gyns and menopause specialists actually practice.

Does the science back this up?

Mostly, yes. The use of combined oral contraceptives (COCs) in perimenopausal symptom management is supported by professional guidelines, though with important caveats around risk stratification. The evidence for transitioning to traditional HRT around age 50 is also solid, though the reasoning is more nuanced than the video lets on.

The North American Menopause Society (NAMS) 2022 position statement confirms that low-dose COCs are an acceptable option for managing vasomotor symptoms in perimenopausal women without contraindications. The estrogen dose in COCs (typically 20-35 mcg ethinyl estradiol) is pharmacologically higher than what's used in standard menopausal HRT, which is relevant to risk. Goldstein et al. (2011, Menopause) documented that COCs suppress endogenous hormone fluctuations and can mask the transition to menopause, which is why the age-50 transition point matters clinically. The Mirena IUD as a progestin source alongside systemic estrogen is well-established in the literature, including work by Suvanto-Luukkonen et al. (1997, Maturitas) and is endorsed by the British Menopause Society.

What did they get right, and where does it get thin?

She got the broad strokes right. Yes, you can still get pregnant in perimenopause. Yes, COCs provide estrogen, progestin, and contraception simultaneously. Yes, transitioning to traditional HRT makes sense when symptoms aren't controlled or when age-related cardiovascular and thromboembolic risk starts to tip the scales. Credit where it's due.

The gaps are in what she didn't say. COCs carry a higher venous thromboembolism (VTE) risk than standard menopausal HRT, and that distinction matters for women over 40 with additional risk factors like smoking, hypertension, or migraine with aura. The MEGA study (Lidegaard et al., 2009, BMJ) documented significantly elevated clot risk with combined pills versus non-use. She also doesn't mention that traditional HRT uses estradiol rather than synthetic ethinyl estradiol, which has a meaningfully different metabolic and risk profile. The omission isn't reckless, but it's a real gap for a video that's reaching tens of thousands of people making actual healthcare decisions.

What should you actually know?

If you're perimenopausal and your doctor is recommending COCs for symptom management, that's a legitimate clinical option. But the conversation needs to include your individual cardiovascular and clotting risk profile, not just your age. COCs are not low-dose HRT. The estrogen is synthetic and the dose is higher, which changes the risk calculation.

The Mirena-plus-estrogen approach is a well-supported option for women who need contraception and symptom relief simultaneously. It's used widely in the UK and is gaining traction in US practice. The transition to standard HRT after 50 is generally sensible because COC risks increase with age and because confirming menopause status becomes relevant for adjusting treatment. A 2017 ACOG committee opinion also notes that healthy, non-smoking perimenopausal women can use COCs up to age 50-55, but individual risk assessment is required, not a blanket recommendation.

• COCs use ethinyl estradiol, not estradiol. The difference in metabolic and clotting risk is real.
• Smoking is an absolute contraindication to COC use over age 35. This was not mentioned.
• Mirena IUD as progestin delivery alongside systemic estrogen is guideline-supported and effective.
• Confirming menopause after stopping COCs typically requires FSH testing, since pills suppress the hormone signal.